These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

710 related items for PubMed ID: 20018889

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Small-molecule conversion of toxic oligomers to nontoxic β-sheet-rich amyloid fibrils.
    Bieschke J, Herbst M, Wiglenda T, Friedrich RP, Boeddrich A, Schiele F, Kleckers D, Lopez del Amo JM, Grüning BA, Wang Q, Schmidt MR, Lurz R, Anwyl R, Schnoegl S, Fändrich M, Frank RF, Reif B, Günther S, Walsh DM, Wanker EE.
    Nat Chem Biol; 2011 Nov 20; 8(1):93-101. PubMed ID: 22101602
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Polymorphic C-terminal beta-sheet interactions determine the formation of fibril or amyloid beta-derived diffusible ligand-like globulomer for the Alzheimer Abeta42 dodecamer.
    Ma B, Nussinov R.
    J Biol Chem; 2010 Nov 19; 285(47):37102-10. PubMed ID: 20847046
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Amyloid-β Peptide Nitrotyrosination Stabilizes Oligomers and Enhances NMDAR-Mediated Toxicity.
    Guivernau B, Bonet J, Valls-Comamala V, Bosch-Morató M, Godoy JA, Inestrosa NC, Perálvarez-Marín A, Fernández-Busquets X, Andreu D, Oliva B, Muñoz FJ.
    J Neurosci; 2016 Nov 16; 36(46):11693-11703. PubMed ID: 27852777
    [Abstract] [Full Text] [Related]

  • 10. The Properties of Amyloid-β Fibrils Are Determined by their Path of Formation.
    Brännström K, Islam T, Gharibyan AL, Iakovleva I, Nilsson L, Lee CC, Sandblad L, Pamrén A, Olofsson A.
    J Mol Biol; 2018 Jun 22; 430(13):1940-1949. PubMed ID: 29751013
    [Abstract] [Full Text] [Related]

  • 11. Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance.
    Antzutkin ON, Leapman RD, Balbach JJ, Tycko R.
    Biochemistry; 2002 Dec 24; 41(51):15436-50. PubMed ID: 12484785
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Amyloid-beta protofibrils differ from amyloid-beta aggregates induced in dilute hexafluoroisopropanol in stability and morphology.
    Nichols MR, Moss MA, Reed DK, Cratic-McDaniel S, Hoh JH, Rosenberry TL.
    J Biol Chem; 2005 Jan 28; 280(4):2471-80. PubMed ID: 15528204
    [Abstract] [Full Text] [Related]

  • 15. Protofibril-Fibril Interactions Inhibit Amyloid Fibril Assembly by Obstructing Secondary Nucleation.
    Hasecke F, Niyangoda C, Borjas G, Pan J, Matthews G, Muschol M, Hoyer W.
    Angew Chem Int Ed Engl; 2021 Feb 08; 60(6):3016-3021. PubMed ID: 33095508
    [Abstract] [Full Text] [Related]

  • 16. Identifying the Template for Oligomer to Fibril Conversion for Amyloid-β (1-42) Oligomers using Hamiltonian Replica Exchange Molecular Dynamics.
    Saha D, Jana B.
    Chemphyschem; 2022 Dec 16; 23(24):e202200393. PubMed ID: 36052514
    [Abstract] [Full Text] [Related]

  • 17. Keampferol-3-O-rhamnoside abrogates amyloid beta toxicity by modulating monomers and remodeling oligomers and fibrils to non-toxic aggregates.
    Sharoar MG, Thapa A, Shahnawaz M, Ramasamy VS, Woo ER, Shin SY, Park IS.
    J Biomed Sci; 2012 Dec 21; 19(1):104. PubMed ID: 23259691
    [Abstract] [Full Text] [Related]

  • 18. Biophysical comparison of soluble amyloid-β(1-42) protofibrils, oligomers, and protofilaments.
    Nichols MR, Colvin BA, Hood EA, Paranjape GS, Osborn DC, Terrill-Usery SE.
    Biochemistry; 2015 Apr 07; 54(13):2193-204. PubMed ID: 25756466
    [Abstract] [Full Text] [Related]

  • 19. Toxic fibrillar oligomers of amyloid-β have cross-β structure.
    Stroud JC, Liu C, Teng PK, Eisenberg D.
    Proc Natl Acad Sci U S A; 2012 May 15; 109(20):7717-22. PubMed ID: 22547798
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.